QIAseq Multimodal Pan-Cancer Panel
The only one-day, low-input sample to sequencing workflow for simultaneous and comprehensive genomic profiling of DNA variants, RNA fusions and assessing TMB/MSI in solid tumors and heme malignancies
- QIAseq enrichment technology is the basis for Multimodal's uniform and complete coverage of targets, including complex genes like CEPBA, and confident detection of known and novel fusions
- Pre-optimized protocol to go from total nucleic acid extraction to preparation of UMI-containing, unique dual-indexed, NGS-ready libraries using a single-day workflow to enhance sensitivity, improve error correction and reduce index hopping
- Pre-configured automation-compatible workflow solution with secondary analysis and variant interpretation for rapid onboarding, faster turnaround time and improved scalability